Compounds for the treatment of influenza

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9828333
APP PUB NO 20140288312A1
SERIAL NO

14354654

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to oseltamivir derivatives as influenza neuraminidase inhibitors for treating influenza infections and to a method for producing said compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHRISTIAN-ALBRECHTS-UNIVERSITAT ZU KIELOLSHAUSENSTRASSE 40 KIEL 24098

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clement, Bernd Kiel, DE 26 55
Kotthaus, Joscha Kiel, DE 4 2
Kotthaus, Jurke Kiel, DE 1 0
Schade, Dennis La Jolla, US 11 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00